Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC

Name: Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC
License: Public Domain

Second Affiliated Hospital, School of Medicine, Zhejiang University

ClinicalTrials.gov · Datasets · License: Public Domain

head and neck cancer, radiotherapy, anti-pd-1/ctla-4 antibody

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 143542
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.